ACG is a leading Track and Trace solution provider for serialization of cartons and bottles at primary, secondary, tertiary and quaternary levels of packaging for regulated markets. Our advanced solutions support majority of product configuration under the serialization mandate. The variety of product lines can cater to all available line level configurations in pharmaceutical plants. We work closely with pharmaceutical companies across the globe as a track and trace implementation partner. We help at every stage - from complete project planning and implementation to process.
ACG’s machines and application integration capabilities with strong service support enable us to cater to every serialization requirement. Our robust solutions can tackle implementation and interoperability challenges faced at level 0 to level 5 in the end-to-end supply chain.
Visit the ACG Worldwide website:www.acg-world.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.